Status:
COMPLETED
Brain and Abdominal Aneurysm Study
Lead Sponsor:
Mayo Clinic
Conditions:
Aneurysm
Eligibility:
All Genders
18+ years
Brief Summary
Aneurysmal subarachnoid hemorrhage (aSAH) is the most deadly kind of stroke. Each year, 40,000 Americans have SAH. Case-fatality approaches 60% and more than half of those who die do so before reachin...
Eligibility Criteria
Inclusion
- Men and women age ≥ 18 years.
- Diagnosis of intracranial aneurysm secured by magnetic resonance angiography (MRA), computed tomographic angiography (CTA), or catheter-based cerebral angiography.
- Diagnosis of subarachnoid hemorrhage diagnosed by head CT, brain MRI or lumbar puncture.
- Provides written informed consent.
- No know diagnosis of aortic aneurysm
- No history of prior screening for aortic aneurysm
- No condition like recent abdominal surgical scar that would preclude abdominal ultrasonography
- No therapy like abdominal hypothermia pads that would preclude abdominal ultrasonography
Exclusion
Key Trial Info
Start Date :
October 11 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 2 2024
Estimated Enrollment :
271 Patients enrolled
Trial Details
Trial ID
NCT01420991
Start Date
October 11 2021
End Date
March 2 2024
Last Update
April 16 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Florida
Jacksonville, Florida, United States, 32224
2
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905